A Fixed-Dose Combination of Bisoprolol and Amlodipine for Hypertension: A Potential Benefit to Selected Patients.

about

A Fixed-Dose Combination of Bisoprolol and Amlodipine for Hypertension: A Potential Benefit to Selected Patients.

Item

http://www.wikidata.org/entity/Q54168962

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

A Fixed-Dose Combination of Bi ...... Benefit to Selected Patients.

@en

A Fixed-Dose Combination of Bi ...... Benefit to Selected Patients.

@nl

type

Item

label

A Fixed-Dose Combination of Bi ...... Benefit to Selected Patients.

@en

A Fixed-Dose Combination of Bi ...... Benefit to Selected Patients.

@nl

prefLabel

A Fixed-Dose Combination of Bi ...... Benefit to Selected Patients.

@en

A Fixed-Dose Combination of Bi ...... Benefit to Selected Patients.

@nl

P1476

A Fixed-Dose Combination of Bi ...... Benefit to Selected Patients.

@en

P2093

Brian J Cohen

http://www.w3.org/2001/XMLSchema#string

P2860

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

Atenolol vs nonatenolol β-blockers for the treatment of hypertension: a meta-analysis

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

24 h blood pressure control with the once daily calcium antagonist, amlodipine

P304

6-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1002/CPDD.325

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28099796

http://www.w3.org/2001/XMLSchema#string